Bicycle Therapeutics

BCYCNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$291.870 M

$4.17 +5.04%

Close of 7 Aug 2026

Revenue

$72.6M

#2622 by revenue

Earnings

-$219.0M

Loss-making

Shares outstanding

69,814,145

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#236Zentalis PharmaceuticalsZNTL$300.4M
#237Fulcrum TherapeuticsFULC$296.8M
#238Bicycle TherapeuticsBCYC$291.9M
#239ImmuneeringIMRX$291.8M
#240Jupiter NeurosciencesJUNS$288.3M

Where these numbers come from

Share counts and financials for Bicycle Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.